The global Acyl CoA Desaturase market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Acyl CoA Desaturase volume and value at global level, regional level and company level. From a global perspective, this report represents overall Acyl CoA Desaturase market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Acyl CoA Desaturase in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Acyl CoA Desaturase manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Daiichi Sankyo Co Ltd
Galmed Pharmaceuticals Ltd
GlaxoSmithKline Plc
Johnson & Johnson
Novartis AG
Sanofi
Thesan Pharmaceuticals, Inc.
Xenon Pharmaceuticals Inc.

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Aramchol
T-3764518
TSN-2898
Others

Segment by Application
Acne Vulgaris
Colorectal Cancer
Liver Fibrosis
Metastatic Renal Cell Carcinoma
Others